Schedule of financial assets at amortised cost |
Half-year to 30 June 2022 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Gross carrying amount | | Allowance for expected credit losses | Stage 1 £m | | Stage 2 £m | | Stage 3 £m | | | POCI £m | | | Total £m | | Stage 1 £m | | Stage 2 £m | | Stage 3 £m | | | POCI £m | | | Total £m | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Loans and advances to banks | At 1 January 2022 | 7,002 | | | | — | | | | — | | | | — | | | | 7,002 | | | | 1 | | | | — | | | | — | | | | — | | | | 1 | | | Exchange and other adjustments | 497 | | | | — | | | | — | | | | — | | | | 497 | | | | — | | | | — | | | | — | | | | — | | | | — | | | Other changes in credit quality | | | | | | | | | | | | | | | | 2 | | | | — | | | | — | | | | — | | | | 2 | | | Additions and repayments | 348 | | | | — | | | | — | | | | — | | | | 348 | | | | 1 | | | | — | | | | — | | | | — | | | | 1 | | | Charge to the income statement | | | | | | | | | | | | | | | | 3 | | | | — | | | | — | | | | — | | | | 3 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | At 30 June 2022 | 7,847 | | | | — | | | | — | | | | — | | | | 7,847 | | | | 4 | | | | — | | | | — | | | | — | | | | 4 | | | Allowance for impairment losses | (4) | | | | — | | | | — | | | | — | | | | (4) | | | | | | | | | | | | | | | | | | Net carrying amount | 7,843 | | | | — | | | | — | | | | — | | | | 7,843 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Loans and advances to customers | At 1 January 2022 | 400,036 | | | | 34,931 | | | | 6,443 | | | | 10,977 | | | | 452,387 | | | | 915 | | | | 1,114 | | | | 1,581 | | | | 210 | | | | 3,820 | | | Exchange and other adjustments1 | 138 | | | | 14 | | | | (21) | | | | 30 | | | | 161 | | | | 1 | | | | — | | | | 19 | | | | 53 | | | | 73 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Transfers to Stage 1 | 8,517 | | | | (8,478) | | | | (39) | | | | | | | — | | | | 173 | | | | (166) | | | | (7) | | | | | | | — | | | Transfers to Stage 2 | (21,796) | | | | 22,078 | | | | (282) | | | | | | | — | | | | (46) | | | | 101 | | | | (55) | | | | | | | — | | | Transfers to Stage 3 | (580) | | | | (2,279) | | | | 2,859 | | | | | | | — | | | | (2) | | | | (74) | | | | 76 | | | | | | | — | | | Impact of transfers between stages | (13,859) | | | | 11,321 | | | | 2,538 | | | | | | | — | | | | (129) | | | | 353 | | | | 178 | | | | | | | 402 | | | | | | | | | | | | | | | | | | | (4) | | | | 214 | | | | 192 | | | | | | | 402 | | | Other changes in credit quality | | | | | | | | | | | | | | | | (171) | | | | (21) | | | | 206 | | | | (8) | | | | 6 | | | Additions and repayments | 11,162 | | | | (2,305) | | | | (509) | | | | (573) | | | | 7,775 | | | | 36 | | | | (33) | | | | (67) | | | | (12) | | | | (76) | | | Methodology and model changes | | | | | | | | | | | | | | | | (2) | | | | (18) | | | | 45 | | | | (22) | | | | 3 | | | Charge (credit) to the income statement | | | | | | | | | | | | | | | | (141) | | | | 142 | | | | 376 | | | | (42) | | | | 335 | | | Advances written off | | | | | | | (428) | | | | (19) | | | | (447) | | | | | | | | | | (428) | | | | (19) | | | | (447) | | | Recoveries of advances written off in previous years | | | | | | | 72 | | | | — | | | | 72 | | | | | | | | | | 72 | | | | — | | | | 72 | | | At 30 June 2022 | 397,477 | | | | 43,961 | | | | 8,095 | | | | 10,415 | | | | 459,948 | | | | 775 | | | | 1,256 | | | | 1,620 | | | | 202 | | | | 3,853 | | | Allowance for impairment losses | (775) | | | | (1,256) | | | | (1,620) | | | | (202) | | | | (3,853) | | | | | | | | | | | | | | | | | | Net carrying amount | 396,702 | | | | 42,705 | | | | 6,475 | | | | 10,213 | | | | 456,095 | | | | | | | | | | | | | | | | | |
1Exchange and other adjustments includes the impact of movements in exchange rates, discount unwind, derecognising assets as a result of modifications and adjustments in respect of purchased or originated credit-impaired financial assets (POCI). Where a POCI asset’s expected credit loss is less than its expected credit loss on purchase or origination, the increase in its carrying value is recognised within gross loans, rather than as a negative impairment allowance. NOTES TO THE CONDENSED CONSOLIDATED HALF-YEAR FINANCIAL STATEMENTS (continued) Note 12: Financial assets at amortised cost (continued) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Gross carrying amount | | Allowance for expected credit losses | Stage 1 £m | | Stage 2 £m | | Stage 3 £m | | | POCI £m | | | Total £m | | Stage 1 £m | | Stage 2 £m | | Stage 3 £m | | | POCI £m | | | Total £m | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Reverse repurchase agreements | At 30 June 2022 | 56,516 | | | | — | | | | — | | | | — | | | | 56,516 | | | | | | | | | | | | | | | | | | Allowance for impairment losses | — | | | | — | | | | — | | | | — | | | | — | | | | | | | | | | | | | | | | | | Net carrying amount | 56,516 | | | | — | | | | — | | | | — | | | | 56,516 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Debt securities | At 1 January 2022 | 6,827 | | | | 9 | | | | 2 | | | | — | | | | 6,838 | | | | 1 | | | | — | | | | 2 | | | | — | | | | 3 | | | Exchange and other adjustments | 359 | | | | — | | | | — | | | | — | | | | 359 | | | | (1) | | | | — | | | | — | | | | — | | | | (1) | | | Transfers to Stage 1 | 9 | | | | (9) | | | | — | | | | | | | — | | | | — | | | | — | | | | — | | | | | | | — | | | Impact of transfers between stages | 9 | | | | (9) | | | | — | | | | | | | — | | | | — | | | | — | | | | — | | | | | | | — | | | | | | | | | | | | | | | | | | | — | | | | — | | | | — | | | | | | | — | | | Other changes in credit quality | | | | | | | | | | | | | | | | 1 | | | | — | | | | — | | | | — | | | | 1 | | | Additions and repayments | 1,787 | | | | — | | | | — | | | | — | | | | 1,787 | | | | 1 | | | | — | | | | — | | | | — | | | | 1 | | | Charge to the income statement | | | | | | | | | | | | | | | | 2 | | | | — | | | | — | | | | — | | | | 2 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | At 30 June 2022 | 8,982 | | | | — | | | | 2 | | | | — | | | | 8,984 | | | | 2 | | | | — | | | | 2 | | | | — | | | | 4 | | | Allowance for impairment losses | (2) | | | | — | | | | (2) | | | | — | | | | (4) | | | | | | | | | | | | | | | | | | Net carrying amount | 8,980 | | | | — | | | | — | | | | — | | | | 8,980 | | | | | | | | | | | | | | | | | | Total financial assets at amortised cost | 470,041 | | | | 42,705 | | | | 6,475 | | | | 10,213 | | | | 529,434 | | | | | | | | | | | | | | | | | |
Year ended 31 December 2021 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Gross carrying amount | | Allowance for expected credit losses | | Stage 1 £m | | | Stage 2 £m | | | Stage 3 £m | | | POCI £m | | | Total £m | | | Stage 1 £m | | | Stage 2 £m | | | Stage 3 £m | | | POCI £m | | | Total £m | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Loans and advances to banks | | At 1 January 2021 | 8,066 | | | | — | | | | — | | | | — | | | | 8,066 | | | | 6 | | | | — | | | | — | | | | — | | | | 6 | | | Exchange and other adjustments | (11) | | | | — | | | | — | | | | — | | | | (11) | | | | — | | | | — | | | | — | | | | — | | | | — | | | Other changes in credit quality | | | | | | | | | | | | | | | | (5) | | | | — | | | | — | | | | — | | | | (5) | | | Additions and repayments | (1,053) | | | | — | | | | — | | | | — | | | | (1,053) | | | | — | | | | — | | | | — | | | | — | | | | — | | | Credit to the income statement | | | | | | | | | | | | | | | | (5) | | | | — | | | | — | | | | — | | | | (5) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | At 31 December 2021 | 7,002 | | | | — | | | | — | | | | — | | | | 7,002 | | | | 1 | | | | — | | | | — | | | | — | | | | 1 | | | Allowance for impairment losses | (1) | | | | — | | | | — | | | | — | | | | (1) | | | | | | | | | | | | | | | | | | Net carrying amount | 7,001 | | | | — | | | | — | | | | — | | | | 7,001 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Loans and advances to customers | | At 1 January 2021 | 375,300 | | | | 51,659 | | | | 6,490 | | | | 12,511 | | | | 445,960 | | | | 1,372 | | | | 2,145 | | | | 1,982 | | | | 261 | | | | 5,760 | | | Exchange and other adjustments1 | (2,686) | | | | (39) | | | | (81) | | | | 68 | | | | (2,738) | | | | (3) | | | | (6) | | | | (1) | | | | 121 | | | | 111 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Transfers to Stage 1 | 18,705 | | | | (18,665) | | | | (40) | | | | | | | — | | | | 564 | | | | (553) | | | | (11) | | | | | | | — | | | Transfers to Stage 2 | (12,009) | | | | 12,724 | | | | (715) | | | | | | | — | | | | (48) | | | | 155 | | | | (107) | | | | | | | — | | | Transfers to Stage 3 | (872) | | | | (1,822) | | | | 2,694 | | | | | | | — | | | | (13) | | | | (220) | | | | 233 | | | | | | | — | | | Impact of transfers between stages | 5,824 | | | | (7,763) | | | | 1,939 | | | | | | | — | | | | (428) | | | | 195 | | | | 221 | | | | | | | (12) | | | | | | | | | | | | | | | | | | | 75 | | | | (423) | | | | 336 | | | | | | | (12) | | | Other changes in credit quality | | | | | | | | | | | | | | | | (245) | | | | (271) | | | | 255 | | | | (48) | | | | (309) | | | Additions and repayments | 21,598 | | | | (8,926) | | | | (1,007) | | | | (1,565) | | | | 10,100 | | | | (221) | | | | (346) | | | | (99) | | | | (87) | | | | (753) | | | Methodology and model changes | | | | | | | | | | | | | | | | (63) | | | | 15 | | | | 6 | | | | — | | | | (42) | | | (Credit) charge to the income statement | | | | | | | | | | | | | | | | (454) | | | | (1,025) | | | | 498 | | | | (135) | | | | (1,116) | | | Advances written off | | | | | | | (1,058) | | | | (37) | | | | (1,095) | | | | | | | | | | (1,058) | | | | (37) | | | | (1,095) | | | Recoveries of advances written off in previous years | | | | | | | 160 | | | | — | | | | 160 | | | | | | | | | | 160 | | | | — | | | | 160 | | | At 31 December 2021 | 400,036 | | | | 34,931 | | | | 6,443 | | | | 10,977 | | | | 452,387 | | | | 915 | | | | 1,114 | | | | 1,581 | | | | 210 | | | | 3,820 | | | Allowance for impairment losses | (915) | | | | (1,114) | | | | (1,581) | | | | (210) | | | | (3,820) | | | | | | | | | | | | | | | | | | Net carrying amount | 399,121 | | | | 33,817 | | | | 4,862 | | | | 10,767 | | | | 448,567 | | | | | | | | | | | | | | | | | |
1Exchange and other adjustments includes the impact of movements in exchange rates, discount unwind, derecognising assets as a result of modifications and adjustments in respect of purchased or originated credit-impaired financial assets (POCI). Where a POCI asset’s expected credit loss is less than its expected credit loss on purchase or origination, the increase in its carrying value is recognised within gross loans, rather than as a negative impairment allowance. NOTES TO THE CONDENSED CONSOLIDATED HALF-YEAR FINANCIAL STATEMENTS (continued) Note 12: Financial assets at amortised cost (continued) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Gross carrying amount | | Allowance for expected credit losses | | Stage 1 £m | | | Stage 2 £m | | | Stage 3 £m | | | POCI £m | | | Total £m | | | Stage 1 £m | | | Stage 2 £m | | | Stage 3 £m | | | POCI £m | | | Total £m | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Reverse repurchase agreements | | At 31 December 2021 | 54,753 | | | | — | | | | — | | | | — | | | | 54,753 | | | | | | | | | | | | | | | | | | Allowance for impairment losses | — | | | | — | | | | — | | | | — | | | | — | | | | | | | | | | | | | | | | | | Net carrying amount | 54,753 | | | | — | | | | — | | | | — | | | | 54,753 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Debt securities | | At 1 January 2021 | 5,406 | | | | — | | | | 2 | | | | — | | | | 5,408 | | | | 1 | | | | — | | | | 2 | | | | — | | | | 3 | | | Exchange and other adjustments | (20) | | | | — | | | | — | | | | — | | | | (20) | | | | — | | | | — | | | | — | | | | — | | | | — | | | Transfers to Stage 2 | (6) | | | | 6 | | | | — | | | | | | | — | | | | — | | | | — | | | | — | | | | | | | — | | | Impact of transfers between stages | (6) | | | | 6 | | | | — | | | | | | | — | | | | — | | | | — | | | | — | | | | | | | — | | | | | | | | | | | | | | | | | | | — | | | | — | | | | — | | | | | | | — | | | Additions and repayments | 1,447 | | | | 3 | | | | — | | | | — | | | | 1,450 | | | | — | | | | — | | | | — | | | | — | | | | — | | | Charge to the income statement | | | | | | | | | | | | | | | | — | | | | — | | | | — | | | | — | | | | — | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | At 31 December 2021 | 6,827 | | | | 9 | | | | 2 | | | | — | | | | 6,838 | | | | 1 | | | | — | | | | 2 | | | | — | | | | 3 | | | Allowance for impairment losses | (1) | | | | — | | | | (2) | | | | — | | | | (3) | | | | | | | | | | | | | | | | | | Net carrying amount | 6,826 | | | | 9 | | | | — | | | | — | | | | 6,835 | | | | | | | | | | | | | | | | | | Total financial assets at amortised cost | 467,701 | | | | 33,826 | | | | 4,862 | | | | 10,767 | | | | 517,156 | | | | | | | | | | | | | | | | | |
|